Literature DB >> 12532126

Cost-effectiveness of pediatric asthma treatments.

Kevin R Murphy.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12532126     DOI： 10.1067/mai.2003.50

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial.

Authors:  Li Wang; Christopher S Hollenbeak; David T Mauger; Robert S Zeiger; Ian M Paul; Christine A Sorkness; Robert F Lemanske; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.